CAS: 1353859-00-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CX6258(HCL) REF: IN-DA009YZ1CAS: 1353859-00-3 | 98% | A consultar | Lun 21 Abr 25 |
 | CX-6258 hydrochloride REF: 54-BUP12580CAS: 1353859-00-3 | 97.21% | 356,00 €~1.522,00 € | Mar 22 Abr 25 |
 | CX-6258 hydrochloride REF: TM-T6148CAS: 1353859-00-3 | 96.03% - 98.00% | 43,00 €~1.236,00 € | Jue 24 Abr 25 |
 | (E)-5-Chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one hydrochloride REF: 3D-DEC85900CAS: 1353859-00-3 | Min. 95% | - - - | Producto descatalogado |
Ref: IN-DA009YZ1
| 1mg | 56,00 € | ||
| 5mg | 107,00 € | ||
| 10mg | 128,00 € | ||
| 25mg | 156,00 € |
Entrega estimada en Estados Unidos, el Lunes 21 de Abril de 2025
Ref: 54-BUP12580
| 25mg | 356,00 € | ||
| 50mg | 562,00 € | ||
| 100mg | 831,00 € | ||
| 200mg | 1.180,00 € | ||
| 500mg | 1.522,00 € |
Entrega estimada en Estados Unidos, el Martes 22 de Abril de 2025
CX-6258 hydrochloride
CAS:1353859-00-3
CX-6258 hydrochloride (Pim-Kinase Inhibitor X) is an effective, orally efficacious Pim1/2/3 kinase inhibitor (IC50: 5/25/16 …
Fórmula:
C26H24ClN3O3·HCl
Pureza:
96.03% - 98.00%
Forma y color:
Solid
Peso molecular:
498.4
Ref: TM-T6148
| 1mg | 43,00 € | ||
| 5mg | 88,00 € | ||
| 10mg | 127,00 € | ||
| 25mg | 235,00 € | ||
| 50mg | 376,00 € | ||
| 100mg | 567,00 € | ||
| 200mg | 805,00 € | ||
| 1mL*10mM (DMSO) | 87,00 € |
Entrega estimada en Estados Unidos, el Jueves 24 de Abril de 2025
(E)-5-Chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one hydrochloride
CAS:1353859-00-3
(E)-5-Chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one hydrochloride is a drug that has been shown to have cancer therapeutic properties. It …
Fórmula:
C26H24ClN3O3·ClH
Pureza:
Min. 95%
Peso molecular:
498.41 g/mol
Ref: 3D-DEC85900
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
